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(maximum duration pending complete follow-up). Two patients
received the 200 units IA BoNT/A injection 8-12 weeks after the
first injection (including the only non-responder).
No increase in joint inflammation, periarticular muscle weakness,
fever or fatigue, or other complications were noted.
Conclusions: I/A BoNT/A significantly decreased refractory
prosthetic joint pain and appeared to be safe. A prospective
randomized trial is underway to confirm these findings.
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Purpose: There is no consensus regarding the optimal strategy
to minimise patients exposure to allogenic blood transfusion. The
majority of current literature suggests tranexamic acid reduces
blood loss following hip and knee arthroplasty.
The aim of this study is to determine whether these findings
are reproducible despite variations in surgical practice, whether
tranexamic acid has any effect on the length of inpatient stay
and whether there are any unwanted complications secondary
to administration.
Methods: Retrospective analysis of case notes.
Included all patients undergoing primary THR and TKR between
Jan 2005 to Dec 2005 under care of the senior author.
74 patients in total.
Aetiology was osteoarthritis in all cases.
Exclusions: Missing case notes 11, no documentation of blood
loss in drain 10
52 patients included in study
26 underwent primary TKR (13 had 1g i.v tranexamic acid
at induction and before release of tourniquet after cementing
prosthesis)
26 underwent primary THR (13 had 1g i.v tranexamic acid at
induction)
39 operated by senior surgeon
13 operated by trainees with senior author supervising
Blood loss in drain, pre and post op Hb, length of inpatient stay
and post operative complications were recorded in all cases.
Differences between the control group and those receiving
tranexamic acid were analysed using a Students T-test, with
p<0.05 taken as statistically significant.
Results: THR (comparing difference between tranexamic acid
group and control).
Mean drop in Hb was less in the tranexamic acid group p=0.019
Mean blood loss in drain was less in the tranexamic acid group
p=0.00039
Mean length of inpatient stay was less in the tranexamic acid
group p=0.012
Number of patients needing transfusion =4 in control group
compared to 0 in the tranexamic acid group
No of post operative P.E = 1 in tranexamic acid group compared
to 0 in the control group TKR (comparing difference between
tranexamic acid group and control).
Mean drop in Hb was less in the tranexamic acid group p=0.299
Mean blood loss in drain was less in the tranexamic acid group
p=0.00039
Mean length of inpatient stay was less in the tranexamic acid
group p=0.0124
No of patients needing transfusion =3 in control group compared
to 1 in the tranexamic acid group
Number of post operative P.E =2 in tranexamic acid group com-
pared to 0 in the control group
Conclusions: This study adds to the body of evidence which
supports the use of tranexamic acid in elective primary hip and
knee arthroplasty.
Statistically significant decreased blood loss in the drain when
administering tranexamic acid during THR and TKR
Statistically significant reduction in the Hb drop post operatively
when administering tranexamic acid during THR.
Clinically significant reduction in inpatient stay in those patients
who received tranexamic acid.
Results achieved despite variations in methodology to previous
studies and variation in surgical technique to previous studies.
Weaknesses of study is selection bias and limited sample size.
More research is required to determine optimum dose and timing
of administration.
The routine use of this antifibrinolytic should be considered for
patients undergoing elective primary THR and TKR.
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Purpose: The objective of this study is to demonstrate that
for medial compartment knee arthritis abrasion arthroplasty and
osteotomy can be a viable alternative to replacement surgery.
Methods: Between 1989 and 2002, 486 medial compartment
abrasion arthroplasties with valgus osteotomy were performed.
The Oxford Knee Questionnaire was sent to 470 patients, of
which 296 were correctly answered. All patients had grade III/IV
(Outerbridge) cartilage lesions.34 patients were bilateral. The
minimum follow-up was 12 months, and the maximum was 14,
4 years, which means an average of 2, 99 years. The abrasion
arthroplasty was performed with an abrader, combined with mi-
cro picks. The osteotomy was a closing-wedge osteotomy, with
proximal fibular lysis and internal fixation. All patients followed a
12-week non-weightbearing protocol.
Results: The mean knee score for patients treated by abrasion
arthroplasty and osteotomy was 38, 10 ± 8, 04. Of the 296
patients,133 (44.93%) had one or more surgeries before the
